Tag: South Korea

Avacta and Daewoong Create a Joint Venture to Develop a New Generation of Immunotherapy

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, and Daewoong Pharmaceutical Co. Ltd., a leading Korean pharmaceutical company, are pleased to announce that they have agreed t...

Can-Fite BioPharma Signed Agreement with Kyongbo Pharm to Distribute Piclidenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced it has signed a distribution a...

South Korea loosens the biotech accounting rules

South Korea's financial regulator announced it will give biotechnology and pharmaceutical companies leeway on listing rules, after allowing them to voluntarily restate accounting errors.

Korean pharma company Yuhan signs licensing deal with Janssen

Yuhan Corporation entered into a licensing agreement with Janssen Biotech to develop Lazertinib, a treatment for non-small cell lung cancer (NSCLC) that is undergoing clinical trials in Korea.

SK Biopharmaceuticals created novel drug development platform

drug discovery
SK Biopharmaceuticals, the new drug development unit of South Korea’s conglomerate SK Group, had finished developing an artificially intelligent drug development and design platform.

Korean scientists unveiled biosensor for optimizing microbial cell factories

A research group at Korea Advanced Institute of Science and Technology (KAIST) presented a novel biosensor which can produce diverse, high-level microbial cell factories.

Merck KGaA gets hold on $117 million contract for Samsung biosimilar

Merck KGaA, a global health care company, has won a $117 million contract to supply the biosimilar Renflexis, developed by Samsung Bioepis Co., to the U.S. Department of Veterans Affairs.

Russia and South Korea will jointly develop biotechnology R&D

The Russian Direct Investment Fund (RDIF), JSFC Sistema, the Medsi Group of Companies, have agreed with the South Korean company Green Cross Cell to develop jointly biotechnology in Russia.

South Korea recalls 59 valsartan-containing drugs

counterfeit drug
South Korea’s Ministry of Food and Drug Safety ordered a recall of 59 drugs containing valsartan due to its inclusion of above-permitted levels of a chemical that could cause cancer.

The finished medicinal product market of South Korea shows significant growth

South Korea's pharmaceutical market is experiencing significant growth in finished drug products, according to CPhI Korea.

Global biotech conference started in South Korea

The 2018 Global Bio Conference kicked off in Seoul, bringing together biotech regulators and industry experts from around the world to support the growth and overseas expansion of South Korea’s biopharmaceutical businesses.

Pharma Research Products gains a generic botulinum toxin production company

Pharma Research Products Company Ltd. (PRP) a Korean company engaged in the development of medical esthetic products, secured majority ownership of botulinum toxin type A injection production facility of BioCND.

Samsung BioLogics is concerned about the accusation of accounting fraud

samsung biologics
South Korea’s major biopharmaceutical firm Samsung BioLogics Co., which has been embroiled in an alleged violation of accounting rules, expressed concern over the local financial regulator’s disclosure of sensitive information.

South Korea will support AI drug development

drug discovery
South Korea’s largest biopharmaceutical business association has kickstarted preparations for a support center that will leverage artificial intelligence to help pharmaceutical companies accelerate new drug development processes

South Korea doubles its investments in the pharmaceutical sector

South Korea pledged to double its investments in the pharmaceutical sector to help develop 15 new drugs in the next five years